Goodpasture Syndrome: Multimedia

References

1. Shinjo SK, Hasegawa EM, Costa Malheiros DM, Levy-Neto M. [Goodpasture's syndrome]. Acta Reumatol Port. Apr-Jun 2008;33(2):220-3. [Medline].

2. Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med. Dec 1 1967;126(6):989-1004. [Medline]. [Full Text].

3. USRDS. Annual Data Report. United States Renal Data System. Available at http://www.usrds.org/adr.htm. Accessed February 12, 2009.

4. Miklovicova D, Cornelissen M, Cransberg K, Groothoff JW, Dedik L, Schroder CH. Etiology and epidemiology of end-stage renal disease in Dutch children 1987-2001. Pediatr Nephrol. Aug 2005;20(8):1136-42. [Medline].

5. Donaghy M, Rees AJ. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet. Dec 17 1983;2(8364):1390-3. [Medline].

6. Goligher EC, Detsky AS. Migratory pulmonary infiltrates. Goodpasture syndrome. CMAJ. Jan 6 2009;180(1):75-7. [Medline].

7. Arzoo K, Sadeghi S, Liebman HA. Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab). Ann Rheum Dis. Oct 2002;61(10):922-4. [Medline].

8. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. Jun 5 2001;134(11):1033-42. [Medline].

9. Knoll G, Cockfield S, Blydt-Hansen T, et al. Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ. Nov 8 2005;173(10):S1-25. [Medline].

10. Adler S, Cohen AH, Glassock RJ. Secondary glomerular diseases. In: Brenner BM, ed. Brenner & Rector's The Kidney. 5^th ed. Philadelphia, Pa: WB Saunders; 1996:1519-24.

11. Anonymous. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 16-1993. A 13-year-old girl with gross hematuria four years after a diagnosis of idiopathic pulmonary hemosiderosis. N Engl J Med. Apr 22 1993;328(16):1183-90. [Medline].

12. Anonymous. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 52-1993. A 17-year-old girl with massive hemoptysis and acute oliguric renal failure. N Engl J Med. Dec 30 1993;329(27):2019-26. [Medline].

13. Bigler SA, Parry WM, Fitzwater DS, Baliga R. An 11-month-old with anti-glomerular basement membrane disease. Am J Kidney Dis. Nov 1997;30(5):710-2. [Medline].

14. Binstadt BA, Caldas AM, Turvey SE, et al. Rituximab therapy for multisystem autoimmune diseases in pediatric patients. J Pediatr. Nov 2003;143(5):598-604. [Medline].

15. Boven K, Miljoen HP, Van Hoeck KJ, Van Marck EA, Van Acker KJ. Anti-glomerular basement membrane glomerulopathy in a young child. Pediatr Nephrol. Dec 1996;10(6):745-7. [Medline].

16. Gilvarry J, Doyle GF, Gill DG. Good outcome in anti-glomerular basement membrane nephritis. Pediatr Nephrol. May 1992;6(3):244-6. [Medline].

17. Harrity P, Gilbert-Barness E, Cabalka A, Hong R, Zimmerman J. Isolated pulmonary Goodpasture syndrome. Pediatr Pathol. Jul-Aug 1991;11(4):635-46. [Medline].

18. Kelly PT, Haponik EF. Goodpasture syndrome: molecular and clinical advances. Medicine (Baltimore). Jul 1994;73(4):171-85. [Medline].

19. Kluth DC, Rees AJ. Anti-glomerular basement membrane disease. J Am Soc Nephrol. Nov 1999;10(11):2446-53. [Medline].

20. Levin M, Rigden SP, Pincott JR, Lockwood CM, Barratt TM, Dillon MJ. Goodpasture's syndrome: treatment with plasmapheresis, immunosuppression, and anticoagulation. Arch Dis Child. Sep 1983;58(9):697-702. [Medline].

21. Rituxan (Rituximab) package insert. FDA approval date Feb 28, 2006. Genentech, Inc. South San Francisco, CA 94080.

22. Robertson J, Wu J, Arends J, et al. Characterization of the T-cell epitope that causes anti-GBM glomerulonephritis. Kidney Int. Sep 2005;68(3):1061-70. [Medline].

23. Savage COS. Goodpasture's syndrome and anti-GBM disease. In: Greenberg A, ed. Primer on Kidney Diseases. 2^nd ed. San Diego, Ca: Academic Press; 1998:175-9.

24. Siegler RL, Bond RE, Morris AH. Treatment of Goodpasture's syndrome with plasma exchange and immunosuppression. Clin Pediatr (Phila). Jul 1980;19(7):488-91. [Medline].

25. Srivastava RN, Moudgil A, Bagga A, Vasudev AS, Bhuyan UN, Sundraem KR. Crescentic glomerulonephritis in children: a review of 43 cases. Am J Nephrol. 1992;12(3):155-61. [Medline].

26. Trivedi VA, Malter JS, Guillery E. Pediatric anti-glomerular basement membrane glomerulonephritis. J Clin Apher. 1998;13(2):69. [Medline].

Further Reading

Keywords

Goodpasture syndrome, GS, anti–glomerular basement membrane disease, anti-GBM disease, Goodpasture disease, Goodpasture's disease, pulmonary renal syndrome, Goodpasture's syndrome, Wegener granulomatosis, Wegener's granulomatosis, glomerulonephritis, pulmonary hemorrhage, anti-GBM antibody formation, pulmonary renal syndrome of alveolar hemorrhage, small vessel vasculitis, glomerulonephritis, cigarette smoking, end-stage renal disease, ESRD, systemic lupus erythematosus, SLE, Henoch-Schönlein purpura, HSP, respiratory failure, proteinuria, nephrotic syndrome

Contributor Information and Disclosures

Author

Rudolph P Valentini, MD, Director of Dialysis Services, Associate Professor, Department of Pediatrics, Division of Pediatric Nephrology, Wayne State University and Children's Hospital of Michigan
Rudolph P Valentini, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Nephrology, and American Society of Pediatric Nephrology
Disclosure: Nothing to disclose.

Medical Editor

Girish D Sharma, MD, Associate Professor, Department of Pediatrics, Rush University Medical Center, Rush Children's Hospital; Director of Pediatric Pulmonary Section and Rush Cystic Fibrosis Center
Girish D Sharma, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Thoracic Society, and Royal College of Physicians of Ireland
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Charles Callahan, DO, Professor, Deputy Chief of Clinical Services, Walter Reed Army Medical Center
Charles Callahan, DO is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American College of Osteopathic Pediatricians, American Thoracic Society, Association of Military Surgeons of the US, and Christian Medical & Dental Society
Disclosure: Nothing to disclose.

CME Editor

Mary E Cataletto, MD, Associate Director, Division of Pediatric Pulmonology, Winthrop University Hospital; Professor of Clinical Pediatrics, State University of New York at Stony Brook; Director of Children's Sleep Services, Winthrop University Hospital
Mary E Cataletto, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Chest Physicians
Disclosure: Shering Plough Pharmaceuticals Honoraria Consulting

Chief Editor

Michael R Bye, MD, Professor of Clinical Pediatrics, Division of Pulmonary Medicine, Columbia University College of Physicians and Surgeons; Attending Physician, Pediatric Pulmonary Medicine, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University Medical Center
Michael R Bye, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, and American Thoracic Society
Disclosure: Merck Honoraria Speaking and teaching